Clinical Trial Technology Opportunity Assessment

A senior director in R&D at an F100 pharma company wanted to conduct a landscape analysis of technology trends and innovation impacting Phase 3 clinical trials in immunology to improve speed, effectiveness, and patient/provider experience.

BTG delivered a digital health strategy consultant with 20+ years of diverse strategic advisory, market access, and competitive intelligence experience. The consultant had previously spearheaded a range of initiatives for top biopharma companies to inform digital health and launch strategies. On this project, the consultant identified key players and areas of opportunity, anticipated disruptive competitor developments, and pinpointed ways to achieve competitive advantage. The output delivered by the talent served to inform the digital health strategy for the Immunology R&D team.

Previous Article
Assess and Improve Your Remote Work Habits: 6 Steps to Get Started
Assess and Improve Your Remote Work Habits: 6 Steps to Get Started

Experienced independent professional Jamie Johnson shares her best tips for increasing your productivity an...

Next Article
Overcoming Seasonal Affective Disorder (SAD) as a Working Professional
Overcoming Seasonal Affective Disorder (SAD) as a Working Professional

Symptoms of Seasonal Affective Disorder (SAD) such as lethargy and apathy can make a big impact on your pro...

Join the talent revolution with BTG.

Apply Today